Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
about
Impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirinGastroprotective effects of combination of hot water extracts of turmeric (Curcuma domestica L.), cardamom pods (Ammomum compactum S.) and sembung leaf (Blumea balsamifera DC.) against aspirin-induced gastric ulcer model in ratsGastroprotective Effect of Combination of Hot Water Extracts of Licorice (Glycyrrhiza glabra), Pulasari Stem Bark (Alyxia reinwardtii), and Sembung Leaf (Blumea balsamifera) Against Aspirin-Induced Gastric Ulcer Model Rats.Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin ConsumersIncreased susceptibility of aging gastric mucosa to injury: the mechanisms and clinical implications.Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.Concurrent Use of Low-Dose Aspirin and Omega-3 Fatty Acids and Risk of Upper Gastrointestinal Complications: A Cohort Study with Nested Case-Control Analysis.Clinicians' Reports in Electronic Health Records Versus Patients' Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin.Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents.Endoscopic findings for predicting gastric acid secretion status.Time trends in gastroparesis treatment.Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions.Relationship between Adverse Gastric Reactions and the Timing of Enteric-Coated Aspirin Administration.Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy.
P2860
Q34177563-E5B9BBB4-9189-447E-9984-602A7431F8D9Q35237198-AA16C959-F324-4F09-B48E-C1FCF7A46530Q35956780-1E05CC48-6C33-4041-8406-FB4342F2E22DQ36094923-FF84F12A-40CA-438C-B6EA-94C33D702513Q36551017-8FA128F0-A058-40EC-9848-5045D2A309F2Q37192996-AFB8E3F2-FEEA-4934-8DDE-590BF53508D6Q37724637-918B26FC-5699-4047-BF47-2CDD7FEB83FAQ38211000-7661D08D-9184-4C81-B5C0-8C8C5917C9E3Q38413018-DE0CB696-2ACC-430A-9DC4-94D8F8FB65BFQ38926816-912A7100-DEB9-44C9-AACF-9C48D9EEACB7Q39064353-F41319A5-5AA0-492A-A81F-29A0125DCFADQ41565059-61B23718-FD1A-4F21-9F50-6F0AAB762338Q43546348-5FD50024-6B32-412D-85C6-165F577D87C0Q47133431-1E6F7D52-62CA-4243-BFCB-C95316A5E0E3Q47801037-F49621B3-F034-46BB-AE8E-41C80FEF7737Q49355765-BB3AB3AF-BB63-4AF2-94B2-17B83739EEF0Q51036362-011D1634-5C75-4614-BB8F-85925AD2A8DE
P2860
Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Clinical features of gastroduo ...... term low-dose aspirin therapy.
@en
Clinical features of gastroduo ...... term low-dose aspirin therapy.
@nl
type
label
Clinical features of gastroduo ...... term low-dose aspirin therapy.
@en
Clinical features of gastroduo ...... term low-dose aspirin therapy.
@nl
prefLabel
Clinical features of gastroduo ...... term low-dose aspirin therapy.
@en
Clinical features of gastroduo ...... term low-dose aspirin therapy.
@nl
P2093
P2860
P356
P1476
Clinical features of gastroduo ...... -term low-dose aspirin therapy
@en
P2093
Junichi Iwamoto
Yasushi Matsuzaki
Yoshifumi Saito
P2860
P304
P356
10.3748/WJG.V19.I11.1673
P407
P50
P577
2013-03-01T00:00:00Z